[1] Ling CC, Humn J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):551-560.
[2] Thornton AF, Sandier HM, Ten Haken RK, et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms[J]. Int J Radiat Oncol Biol Phys, 1992, 24(4):767-775.
[3] Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography[J]. Semin Nucl Med, 2003, 33(2):148-162.
[4] Pirotte B, Goldman S, Massager N, et al. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas[J]. J Nucl Med, 2004, 45(8):1293-1298.
[5] Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C] L-methionine positron emission tomography:local comparison with stereotactic histopathology[J]. Clin Cancer Res, 2004, 10(21):7163-7170.
[6] Levivier M, Massager N, Wikler D, et al. Use of stereotactic PET Images in dosimetry planning of radiosurgery for brain tumors:clinical experience and proposed classification[J]. J Nucl Med,2004, 45(7):1146-1154.
[7] Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas[J]. J Neurooncol, 2003, 64(3):227-237.
[8] Giammarile F, Houzard C, Bournaud C, et al. High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications[J]. J Neurooncol, 2004, 68(3):263-274.
[9] Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG[J]. J Nucl Med,2005, 46(6):945-952.
[10] Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma[J]. Eur J Nucl Med Mol Imaging, 2003, 30(6):868-873.
[11] Dhermain F, Ducreux D, Bidault F, et al. Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma[J]. Bull Cancer, 2005, 92(4):333-342.